Quantbot Technologies’s Structure Therapeutics GPCR Stock Holding History

Quantbot Technologies’s Portfolio GPCR Stock Details GPCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$219K	Buy	+6,991	New	+$328K	0.01%	1310
2025 Q3	–	Sell	-2,888	Closed	-$59.9K	–	1886
2025 Q2	$59.9K	Sell	2,888 -11,513	-80%	-$253K	﹤0.01%	1472
2025 Q1	$249K	Buy	+14,401	New	+$353K	0.01%	1083
2024 Q3	–	Sell	-7,105	Closed	-$279K	–	1594
2024 Q2	$279K	Buy	+7,105	New	+$292K	0.01%	892

Other funds holding GPCR

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return

Capitolis Liquid Global Markets New York $22.4B AUM 40.52% 1-Year Est. Return

Pacific Heights Asset Management San Francisco, California $3.1B AUM 37.54% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Quantbot Technologies's GPCR Position: Q3 2026 in Review

Quantbot Technologies opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 6,991 shares worth $219K. The stake represents 0.01% of the portfolio and ranks #1310 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in GPCR as recently as Q2 2025.

Quantbot Technologies first reported a position in GPCR in Q2 2024 and has held it in 4 quarters since. The position peaked at $279K in Q2 2024. 113 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

Quantbot Technologies held 6,991 shares of Structure Therapeutics worth $219K as of Q3 2026.
Structure Therapeutics was a new Quantbot Technologies position in Q3 2026.
Structure Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q3 2026, its #1310 holding.
Quantbot Technologies first reported a position in Structure Therapeutics in Q2 2024 and has held it in 4 quarters since.
Quantbot Technologies's Structure Therapeutics position peaked at $279K in Q2 2024.
113 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Quantbot Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.